Safety Watch

Watch this space for the latest safety headlines.

Finally the Food and Drug Administration has issued a new warning that people taking antidepressant drugs should be monitored for a wide spectrum of potentially dangerous changes in mood or personality. These changes range from sucidical and hostile behaviors to mania and extreme euphoria.

Drug Safety Research has completed two new studies about the safety of antidepressant drugs. The first study reveals that use in children doubled in just four years, and identifies new safety concerns. The second study examines adverse event reports about potentially dangerous personaly changes in both children and adults. For copies of the full reports, visit our our Library

A new report from the Democratic staff of the House Committee on Government Reform concluded that FDA is moving more slowly and less often against drug companies for violating drug advertising regulations.

The committee also sent the FDA a collection of false or misleading advertisments which it said should have warranted more forceful and prompt action.

Download a copy from our Library.

Reports & Resources

Download copies or use links to useful documents about drug safety. Examples from our library:

• Guide to interpreting adverse event reports
• Reported adverse events in children < 2 years
• Limited efficacy of antidepressant drugs
• Getting information from the FDA fast
• MedWatch reporting form